Background
History of dTRA
Identifier | Title | Country | Study type | Estimated Enrollment | Time | Status |
---|---|---|---|---|---|---|
NCT03292367 | The Procedural Success and Complication Rate of the Left Distal Radial Approach | Korea | Cohort | 200 | October 2017–February 2018 | Completed |
NCT03373565 | Snuff-box Deep Palmar Arch Artery Versus Radial Angiography | Iran | Randomized | 200 | July 2017–December 2017 | Unknown |
NCT03486470 | Comparison of Two Radial Artery Segments Related to “Old-Fashioned” Radial and New Snuff Box Vessel Approach by US | Bulgaria | Cross-Sectional | 520 | April 2018–August 2018 | Not yet recruiting |
NCT03611725 | Comparison of Success Rate Between Distal RadialApproach and Radial Approach in STEMI | Korea | Randomized | 352 | August 2018–October 2020 | Recruiting |
NCT03789279 | Observational Study of Hand Function After DistalTransradial Access for Angiography | United Kingdom | Cohort | 40 | Janaury 2019- June 2020 | Active, not recruiting |
NCT03794687 | The Distal (SnUffbox) Radial artERy Access for Coronary Angiography and Interventions (SUPER-Prospective) | United States | Cohort | 100 | April 2019-Janaury 2020 | Recruiting |
NCT03863652 | Optimal Hemostasis Duration for Percutaneous Coronary Intervention Via Snuffbox Approach (HEMOBOX) | Korea | Cohort | 200 | December 2019–February 2020 | Recruiting |
NCT03948165 | Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention. | Mexico | Cohort | 100 | November 2017–December 2018 | Completed |
NCT03986151 | Anatomical sNuffbox for Coronary anGiography and IntervEntions (ANGIE) | Greece | Randomized | 774 | June 2019–February 2021 | Recruiting |
NCT04023838 | Randomized Comparison of Radiation Exposure in Coronary Angiography Between Right Conventional and Left Distal Radial Artery Approach | Korea | Randomized | 100 | August 2019–December 2020 | Not yet recruiting |
NCT04080700 | Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA) | Korea | Cohort | 5000 | September 2019–December 2020 | Recruiting |
NCT04125992 | Distal Radial Artery vs. Forearm Radial Artery For Cardiac Catheterization | Palestine | Randomized | 200 | December 2018-Janaury 2020 | Recruiting |
NCT04171570 | DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention | Multi-countries | Randomized | 130 | November 2019–November 2020 | Recruiting |
NCT04194606 | CORonaRy Angiography and intErventions Via Distal vs Proximal aCcess | Germany | Randomized | 500 | December 2019–December 2021 | Not yet recruiting |
NCT04238026 | Distal Radial Artery Approach to Prevent Radial Artery Occlusion (DAPRAO) | Mexico | Randomized | 268 | May 2019–March 2020 | Recruiting |
Year | First author | Country | Study design | Access site | Number (n) | Age (Mean, y) | Male (%) | Success rate (%) | ACS (%) | PCI (%) | ≥6F Sheath (%) | Right (%) | Diameter (Mean, mm) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2017 | Kiemeneij F [21] | Netherlands | Case-series | DRA | 70 | 68 | 79 | 89 | NA | 36 | 58 | 0 | NA |
2018 | Soydan E [22] | Turkey | Case-series | DRA | 54 | 59.3 | 80 | 100 | 31.4 | 8.5 | 100 | 0 | NA |
2018 | Valsecchi O [23] | Italy | Case-series | DRA | 52 | 68 | 82 | 90 | 9.6 | 48.1 | 98.1 | 84.6 | 2.22 |
2018 | Kim Y [24] | South Korea | Retrospective | DRA | 150 | 65.9 | 71.2 | 93.3c | 43.9 | 27.3 | 100 | 0 | 2.57 |
2018 | Lee JW [25] | South Korea | Prospective | DRA | 200 | 66.1 | 66 | 95.5 | 31 | 43.5 | 33.0 | 0 | 2.41a/2.36b |
2018 | Ziakas A [26] | Greece | Case-series | DRA | 49 | 64 | 63.3 | 91.8c | 24.5 | 18.2 | 79.6 | 100 | NA |
2018 | Babunashvili A [27] | Russia | Retrospective | DRA | 1320 | 63.2 | 68.1 | 99.7 | NA | 47.6 | 45.6 | 80.9 | 2.13 |
2018 | Al-Azizi KM [28] | America | Case-series | DRA | 61 | 70 | 75.4 | 98.4 | 73.7 | 55.7 | 86.9 | 0 | NA |
2018 | Flores EA [29] | Georgia | Retrospective | DRA | 200 | 64 | 69 | 95.5 | 51.0 | 28 | NA | 85 | NA |
2019 | Mizuguchi Y [30] | Japan | Retrospective | DRA | 228 | 71.1 | 71.1 | 100 | NA | 33.8 | 29 | 88.6 | 2.4 |
2019 | Norimatsu K [31] | Japan | Retrospective | DRA | 74 | 70 | 78 | 92 | 8 | 40 | 23 | 84 | 2.6 |
2019 | Wretowski D [32] | Poland | Case-series | DRA | 218 | 68 | 65.14 | 89.4 | 19.72 | 36.2 | 56.9 | 51 | NA |
2019 | Gasparini GL [33] | Italy | Prospective | DRA | 47 | 67.8 | 75.6 | 82.9 | NA | 100 | 100 | NA | NA |
2019 | Uddin MJ [34] | Bangladesh | Case-series | DRA | 200 | 52.3 | 75 | 98.5 | NA | 36 | NA | 100 | NA |
2019 | Amin MR [35] | Bangladesh | Case-series | DRA | 100 | NA | NA | 98 | NA | NA | NA | NA | NA |
2020 | Yu WW [36] | China | Case-series | DRA | 92 | 69 | 62.0 | 95.7 | 48.9 | 42.4 | 100 | 95.7 | 1.71 |
2017 | Kaledin A [37] | Russia | Retrospective | DRAd | 2 696 | NA | NA | 97.7 | NA | NA | 99.6 | NA | 2.4 |
TRA | 2781 | NA | NA | 96 | NA | NA | 99.3 | NA | 2.7 | ||||
2018 | Coughlan JJ [38] | Iran | Non randomized control study | DRA | 47 | 61 | 83 | 100 | NA | 0 | 10.6 | 0 | NA |
TRA | 47 | 61.8 | 74.5 | 100 | NA | 0 | 17.1 | 0 | NA | ||||
2018 | Roghani-Dehkordi F [39] | Iran | Cross-sectional study | DRA | 235 | NA | 76.5 | 94.1 | NA | 28.9 | NA | NA | NA |
Trans-palmar | 175 | NA | 76 | 90.8 | NA | 18.2 | NA | NA | NA | ||||
2018 | Koutouzis M [40] | Greece | Randomized control study | DRA | 100 | 63.8 | 74 | 70 | NA | NA | NA | NA | NA |
TRA | 100 | 62.8 | 77 | 98 | NA | NA | NA | NA | NA | ||||
2018 | Gajurel RM [41] | Nepal | Prospective study | DRA | 82 | 57.7 | 58.5 | 97.6 | NA | 24.3 | 65.8 | 100 | NA |
TRA | 82 | 57.2 | 53.6 | 96.4 | NA | 39.0 | 71.9 | 100 | NA | ||||
2019 | Aoi S [42] | America | Retrospective | DRA | 202 | 69.2 | 64.9 | 99.5 | NA | 44.6 | NA | 88.1 | NA |
TRA | 206 | 68.8 | 62.6 | 99 | NA | 44.7 | NA | 90.8 | NA | ||||
2019 | El Tahaan M [43] | Egypt | Non randomized control study | DRA | 50 | 53.42 | 70.0 | 92 | NA | 36 | NA | 44 | NA |
TRA | 50 | 54.07 | 72.0 | 100 | NA | 34 | NA | 44 | NA | ||||
2019 | Mori S [44] | Japan | Prospective | DRA | 43 | NA | NA | 92.9 | NA | 35.9 | NA | NA | NA |
TRA | 53 | NA | NA | 94.3 | NA | 41.1 | NA | NA | NA | ||||
2019 | Vefalı V [45] | Turkey | Non randomized control study | DRA | 102 | 60.89 | 70.6 | 95.1 | NA | 23.53 | NA | 15 | 2.05 |
TRA | 103 | 59.84 | 68 | 96.1 | NA | 24.27 | NA | 18 | 2.32 |
Anatomy of the DRA
Feasibility
Complications
RAO
Bleeding, haematoma and pseudoaneurysm
Numbness
Pain
Application of ultrasound in the dTRA
Measurement of the diameter of the DRA
Advantages of using ultrasound in the perioperative period
Application in cerebral angiography and intervention
Year | First author | Country | Study design | Age (Mean, y) | Sample size (n) | Male (%) | A/I | Glidesheath | Success rate (%) |
---|---|---|---|---|---|---|---|---|---|
2018 | McCarthy DJ [63] | American | Case report | NA | 2 | NA | A/I | 5F Glidesheath Slender/0.88″ sheathless guide catheter | 100.0 |
2019 | Al Saiegh F [64] | American | Case report | 53 | 1 | 0.0 | I | 5French short sheath | 100.0 |
2019 | Brunet MC [65] | American | Retrospective | 53.8 | 85 | 21.2 | A | 5F Glidesheath Slender (Terumo, Japan) | 91.8 |
2019 | Nardai S [66] | Hungary | Retrospective | NA | 58 | NA | A/I | 4-5F transradial sheaths (Terumo Co., Japan)/6.5F JR5 sheathless guiding (Asahi, Japan) | 100.0 |
2019 | Patel P [67] | American | Retrospective | 54.5 | 31 | 50.0 | A | 5F Prelude Ideal (Merit Medical, South Jordan, Utah) or 5F Glidesheath Slender (Terumo, Somerset, New Jersey) | 87.10 |